Vertex Pharmaceuticals, Inc. (VRTX)

450.71 -2.65 (-0.58%) USD  |  NASDAQ  |  Jan 02, 14:02
More

Vertex Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
IDEXX Laboratories, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade